NEWSROOM

NYSE

PRISM MarketView Launches Precious Metals Index for Global Market Insights

PRISM MarketView Launches Precious Metals Index for Global Market Insights

Aug 24, 2025

https://open.spotify.com/episode/6CpLLjXQUPB0lCUYoRMB9y PRISM MarketView Launches Precious Metals Index for Global Market Insights New York, August 25, 2025 - PRISM MediaWire - PRISM MarketView, a prominent provider of market insight and company news, announced on August 21, 2025, the launch of its PRISM Precious Metals Index. This new index is designed to track both emerging and established companies within the global gold, silver, platinum, and palladium sectors. It aims to highlight firms...

PRISM MarketView Launches Precious Metals Index to Track Global Demand and Market Dynamics

PRISM MarketView Launches Precious Metals Index to Track Global Demand and Market Dynamics

Aug 21, 2025

New Index Showcases Companies Positioned to Accelerate the Flourishing Precious Metals Market Key Takeaways PRISM MarketView Launches Precious Metals Index – The new index tracks top innovators in gold, silver, platinum, and palladium sectors, offering investors a data-driven view of market dynamics and growth opportunities. Rising Global Demand and Industrial Expansion – The $306.44 billion precious metals market is projected to exceed $501 billion by 2032, fueled by gold’s safe-haven status,...

Agentic AI: A Strategic Forecast and Market Analysis (2025-2030)

Agentic AI: A Strategic Forecast and Market Analysis (2025-2030)

Jul 15, 2025

• A Transformative Shift in AI Capabilities: Agentic AI represents a fundamental evolution from reactive tools to proactive, autonomous systems capable of pursuing complex, long-term goals, making independent decisions, and executing multistep workflows without continuous human intervention. Unlike traditional AI, which operates on predefined rules, or generative AI that responds reactively to prompts, Agentic AI proactively initiates actions, orchestrates complex workflows, and adapts...

PRISM MediaWire: Trusted Press Release Distribution Service

PRISM MediaWire: Trusted Press Release Distribution Service

Jun 16, 2025

https://www.youtube.com/watch?v=RaomfJxdEdo&ab_channel=PRISMMediaWire Key Highlights: Strategic Press Release Distribution Services that Maximize Market VisibilityPRISM MediaWire leverages an expansive distribution network and direct access to top financial and trade media outlets to ensure every press release reaches the right audience. This strategic approach positions clients at the forefront of capital markets discussions, driving measurable brand visibility. All-Inclusive Press...

PRISM MediaWire – Press Releases Highlights – December 09 to November 13, 2024

Dec 13, 2024

New York, New York, December 13, 2024 - PRISM MediaWire continued to spotlight groundbreaking stories and transformative announcements shaping industries worldwide this week. From innovative product launches and strategic partnerships to impactful social initiatives, our newsroom captured the pulse of global markets and trends. As 2024 draws to a close, these highlights underscore the resilience, creativity, and forward momentum of businesses and organizations driving change. Dive into this...

ClearTrust Announces Integration with VOTR to Transform Shareholder Communications

ClearTrust Announces Integration with VOTR to Transform Shareholder Communications

Nov 12, 2024

Creates New Standard for Shareholder Management Capabilities Enables Unprecedented Data-Driven Insights for Issuers TAMPA, Fla., Nov. 12, 2024 - PRISM MediaWire - Setting a new standard in transfer agent services, ClearTrust, LLC ("ClearTrust") today announced its integration with VOTR's technology-enabled proxy and shareholder communications platform. This strategic integration marks an industry first and represents a significant advancement in how public companies manage and track their...

PRISM MarketView Joins ThinkEquity Conference as Official Media Sponsor

PRISM MarketView Joins ThinkEquity Conference as Official Media Sponsor

Oct 21, 2024

NEW YORK, October 21, 2024 – PRISM MediaWire - PRISM MarketView is proud to announce its role as the official media sponsor for the upcoming ThinkEquity Conference, a premier event bringing together investors, innovators, and industry leaders. The conference will be held at the Mandarin Oriental New York on Oct. 30, offering an exceptional platform for companies and investors to connect, collaborate and explore emerging opportunities. The ThinkEquity Conference is hosted by ThinkEquity, a...

PRISM MarketView Launches AI Infrastructure and Datacenter Index

PRISM MarketView Launches AI Infrastructure and Datacenter Index

Aug 1, 2024

New Index Showcases Companies Positioned to Fuel the Booming AI Market NEW YORK, August 01, 2024-- PRISM MarketView, a leading provider of unbiased market insight and company news, today announces the launch of its PRISM Emerging AI Infrastructure and Datacenter Index in response to significant global growth and interest in AI technology. The new PRISM index tracks emerging companies supplying AI-related infrastructure and the datacenters that store this technology. The global AI market...

American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on Tuesday, June 25, 2024

American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on Tuesday, June 25, 2024

May 21, 2024

Meeting Will be Held at The Hilton Hotel, San Francisco, CA SAN FRANCISCO, CA, May 21, 2024—American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announced that its Annual Meeting of Shareholders will be held on Tuesday, June 25, 2024, at 9:00 a.m. PT. The Annual Meeting will be an in-person meeting. For those who wish to attend, the...

American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on Tuesday, June 25, 2024

American Shared Hospital Services Reports First Quarter 2024 Financial Results

May 14, 2024

- Reports Record Backlog of $210 million more than doubling following the acquisition of Rhode Island Radiation Therapy Cancer Centers in May 2024 - - Remains on track with opening new Puebla, Mexico center - -Conference Call Today, May 14th at 4:30 pm ET - SAN FRANCISCO, CA, May 14, 2024—American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy cancer treatment systems...

Oncocyte to Announce First Quarter 2024 Financial Results

Oncocyte to Announce First Quarter 2024 Financial Results

May 13, 2024

Conference Call and Webcast on Wednesday, May 15, 2024 at 1:30 p.m. PT / 4:30 p.m. ET IRVINE, CA, May 13, 2024 - Oncocyte Corporation (NASDAQ: OCX), a precision diagnostics company, announced today that the company will release its first quarter 2024 financial results on Wednesday, May 15, 2024, after U.S. market close. The company will host a conference call and webcast on Wednesday, May 15, 2024, at 4:30 p.m. Eastern Time to discuss its financial results and highlights. Interested parties...

American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on Tuesday, June 25, 2024

American Shared Hospital Services Announces Closing of Acquisition of 60% Majority Interest in Three Radiation Therapy Cancer Centers in Rhode Island

May 9, 2024

- Adds $9-$10 million in Annual Revenue with Positive Net Income Contribution - - Acquisition more than Doubles Backlog to over $210 million - - Expands U.S. Footprint and Product Offering - SAN FRANCISCO, CA, May 9, 2024—American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy cancer treatment systems and services, today announced the closing of its acquisition of a...

Potencial de desarrollo de la Industria del Litio

May 7, 2024

New York City, 7 de mayo de 2024 Potencial de desarrollo de la Industria del Litio Obtenga el nuevo informe sin costo El equipo de Vostock Capital ha preparado un informe basado en una encuesta realizada a los +400 participantes en el Congreso Litio America latina 2023, entre los participantes encuestados: personal de los ministerios de minas y energías de América Latina, periodistas de minería, altos ejecutivos de las empresas mineras de Litio, gerentes de las empresas proveedoras de la...

Development Potential of the Lithium Industry

May 7, 2024

New York City, May 07, 2024 Development Potential of the Lithium Industry Get the new report for free The Vostock Capital team has prepared a report based on a survey carried out at the Lithium Latin America 2023 Congress about the development potential of the lithium industry. The survey was conducted among governmental authorities, leading industry companies, mining association presidents, mining journalists, and industry providers, which will cover: LATAM countries with the most favorable...

American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on Tuesday, June 25, 2024

American Shared Hospital Services Announces First Quarter 2024 Earnings Conference Call

May 7, 2024

SAN FRANCISCO, CA, May 7, 2024—American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announced that the Company will hold a conference call to discuss its first quarter 2024 financial results on Tuesday, May 14th at 4:30 pm ET / 1:30 pm PT. The first quarter 2024 financial results press release will be issued at the market close on...

PRISM MarketView – Weekly Market Report – April 26, 2024

PRISM MarketView – Weekly Market Report – April 26, 2024

Apr 26, 2024

PRISM Market Pulse: Equities Rally Amid Mixed Big Tech Earnings; Economic Shifts and Sector-Specific Highlights New York, N.Y., April 26, 2024 - PRISM MarketView - Equities were higher through the morning into midday trading as the S&P 500 and Nasdaq are set to snap their three- and four-week losing streaks. Big tech was the topic of Street-talk this week as some of the Magnificent Seven reported earnings. The reports produced mixed and opposite reactions by the Street as Tesla (TSLA)...

PRISM MarketView – Biotech Breakfast

PRISM MarketView – Biotech Breakfast

Apr 22, 2024

Roche’s Alecensa Gets FDA Green Light; ImmunityBio Gains as PDUFA Date Approaches for Bladder Cancer Drug; Key Drug Trial Failures in 2024 New York, N.Y., April 22, 2024 - PRISM MarketView - Healthcare equities finished mostly higher after a very quiet trading session on Friday. The S&P 500 Healthcare Index closed up +0.32% versus the S&P 500 Index which lost (0.88%) and the XBI settled down (0.78%). A lack of momentum today left Roche stock up by just +0.95% following the FDA greenlit...

PRISM MarketView – Weekly Market Report

PRISM MarketView – Weekly Market Report

Apr 19, 2024

PRISM Market Pulse: Market Tumbles Amid Fed's Rate Stance; Mixed Corporate Earnings Highlight Sector Struggles New York, N.Y., April 19, 2024 - PRISM MarketView - Equities were down in the morning and into midday as the major indices remain on track to notch their third straight week of declines. Fedspeak continues to support the “higher-for-longer” narrative with no urgency to cut rates which has created further sharp outflows and investor skepticism. The Street has taken investors’ pulses in...

PRISM MarketView – Bio Investor Alert

PRISM MarketView – Bio Investor Alert

Apr 18, 2024

New York, N.Y., April 18, 2024 - PRISM MarketView - More than 83,000 new cases of bladder cancer are diagnosed in the US each year, and the illness is responsible for around 17,000 deaths annually. Urothelial carcinoma accounts for 90% of bladder cancers in the US and western Europe, and surgery, followed by chemotherapy or radiation is the current standard of care. There are 24 drugs approved by the FDA for bladder cancer, but due to invasive and life-changing surgical procedures, researchers...

American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on Tuesday, June 25, 2024

American Shared Hospital Services Strengthens Senior Management Structure

Apr 18, 2024

SAN FRANCISCO, CA, April 18, 2024—American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announces changes to strengthen its senior management structure. AMS’ current Executive Chairman, Ray Stachowiak, will take on the role of Executive Chairman and Chief Executive Officer, and the Company’s President, Craig Tagawa, will become...

PRISM MarketView – Biotech Breakfast

Apr 15, 2024

Mobile-Health Network Solutions (MNDR) IPOs; Q32 Bio Surges; EMA Concludes GLP-1 Drugs Not Associated with Suicidal Thoughts New York, N.Y., April 15, 2024 - PRISM MarketView - Healthcare equities finished lower on Friday, in line with broad declines across the market. The S&P 500 Healthcare Index closed down (1.52%) versus the S&P 500 Index which lost (1.46%) and the XBI settled down (3.43%). The European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee concluded...

American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on Tuesday, June 25, 2024

American Shared Hospital Services Announces the Sudden Passing of CEO, Peter Gaccione

Apr 12, 2024

SAN FRANCISCO, CA, April 12, 2024 - American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announces the sudden passing of its Chief Executive Officer, Peter Gaccione. Ray Stachowiak, Executive Chairman of American Shared Hospital Services, said, “On behalf of my colleagues at AMS, we are deeply saddened by the unexpected passing of...

Oncocyte to Announce First Quarter 2024 Financial Results

Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules

Apr 11, 2024

IRVINE, CA, April 11, 2024 - Oncocyte Corporation (NASDAQ: OCX), (“Oncocyte” or the “Company”), a precision diagnostics company, today announced that it has entered into definitive securities purchase agreements (the “Purchase Agreements”) for the purchase and sale of an aggregate of 5,077,387 shares of common stock, at a purchase price of $ 2.9164 per share of common stock, and pre-funded warrants to purchase 342,888 shares of common stock at a purchase price of $2.9163 per pre-funded warrant...

Oncocyte to Announce First Quarter 2024 Financial Results

Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay

Apr 11, 2024

- Bio-Rad expects to make equity investment in support of deal - Agreement provides for global exclusivity in transplant monitoring commercialization - Bio-Rad granted subsequent investment option upon FDA clearance IRVINE, CA, April 11, 2024 - Oncocyte Corporation (NASDAQ: OCX), a precision diagnostics company, today announced a partnership agreement with Bio-Rad Laboratories (NYSE: BIO), a global leader in life science research and clinical diagnostics products, for the...

American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on Tuesday, June 25, 2024

American Shared Hospital Services Reports Fourth Quarter 2023 Financial Results

Mar 27, 2024

- Acquisition of 3 Rhode Island Radiation Therapy Cancer Centers progressing toward closing- - International Cancer Center equipment upgrade completed in Ecuador, Opening new Puebla, Mexico Center in Q2- - Lease extensions signed at 4 of 10 Gamma Knife customer sites – -Sales Pipeline continues to advance- -Conference Call Thursday, March 28th at 12:00 pm ET / 9:00 am PT - SAN FRANCISCO, CA, March 27, 2024 - American Shared Hospital Services (NYSE American: AMS) (the "Company") a leading...

American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on Tuesday, June 25, 2024

American Shared Hospital Services Pays Tribute to Ernest A. Bates, M.D., Founder and Former Chairman and CEO

Mar 26, 2024

Dr. Bates, Pioneering Neurosurgeon and Philanthropist, passed on March 19, 2024 SAN FRANCISCO, CA, March 26, 2024 - American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announced that Company Founder, former Chairman and Chief Executive Officer, and Board Director, Ernest A. Bates, M.D, passed away on Tuesday, March 19th at the age of...

PRISM MARKETVIEW PREVIEWS ANTICIPATED FDA DRUG APPROVALS FOR 2024

Mar 25, 2024

New York, N.Y., March 25, 2024 - PRISM MarketView - Drug development is an arduous, costly and time-consuming process for the teams involved behind the scenes, and the patients anxiously awaiting breakthroughs in different disease areas. It takes 12 years on average for a company to take a drug from discovery to commercialization, and every hard-won FDA approval is a cause for celebration for researchers, companies and the end-users whose lives may be changed by these treatments. The past few...

American Shared Hospital Services Announces Fourth Quarter 2023 Earnings Conference Call

American Shared Hospital Services Announces Fourth Quarter 2023 Earnings Conference Call

Mar 22, 2024

Conference Call on Thursday, March 28th at 12:00 pm ET / 9:00 am PT SAN FRANCISCO, CA, March 22, 2024 - American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announced that the Company will hold a conference call to discuss its fourth quarter 2023 financial results on Thursday, March 28th at 12:00 pm ET / 9:00 am PT. The fourth quarter...

PRISM MarketView Spotlights Companies Leading the Charge in Liver Disease Treatment Following Landmark FDA Approval

PRISM MarketView Spotlights Companies Leading the Charge in Liver Disease Treatment Following Landmark FDA Approval

Mar 18, 2024

New York, N.Y., March 18, 2024 - PRISM MarketView, a leading provider of unbiased market insight and company news, today highlights the FDA’s landmark approval of Rezdiffra™ and the companies leading the charge in developing new, safe, and effective treatments for liver disease. The landmark decision has shone a light on metabolic dysfunction-associated steatohepatitis (MASH), formerly known as non-alcoholic fatty liver disease, a leading cause of liver-related mortality that affects between...

EMPIRE PETROLEUM ANNOUNCES COMMENCEMENT OF PREVIOUSLY ANNOUNCED RIGHTS OFFERING

EMPIRE PETROLEUM ANNOUNCES COMMENCEMENT OF PREVIOUSLY ANNOUNCED RIGHTS OFFERING

Mar 7, 2024

TULSA, Okla., March 7, 2024 - Empire Petroleum Corporation (NYSE American: EP) ("Empire" or the "Company"), an oil and gas company with current producing assets in New Mexico, North Dakota, Montana, Texas, and Louisiana, announced today that it has commenced its previously announced subscription rights offering (“Rights Offering”) pursuant to which it intends to raise gross proceeds of up to approximately $25.0 million. The Company is distributing at no charge to holders of its...